AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. K.
Right arrow Articles by Lim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. K.
Right arrow Articles by Lim, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2002; 179:741-750
© American Roentgen Ray Society


Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced Versus Mangafodipir Trisodium—Enhanced MR Imaging

Seung Kwon Kim1, Seung Hoon Kim, Won Jae Lee, Hana Kim, Jung Wook Seo, Dongil Choi, Hyo K. Lim, Soon Jin Lee and Jae Hoon Lim

1 All authors: Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, Ilwon-Dong, Kangnam-Ku, Seoul 135-710, Korea.

OBJECTIVE. The purpose of our study was to compare the diagnostic accuracy and lesion conspicuity of ferumoxides-enhanced MR imaging with those of mangafodipir trisodium—enhanced MR imaging for the preoperative detection of hepatocellular carcinoma.

SUBJECTS AND METHODS. Twenty-one patients with 39 hepatocellular carcinomas underwent ferumoxides-enhanced and mangafodipir trisodium—enhanced MR imaging. The diagnosis was established by pathologic examination after surgical resection in all patients. Five MR sequences were obtained 30 min after ferumoxides administration, and two MR sequences were obtained before and 15 min after mangafodipir trisodium administration. Three observers independently interpreted both MR images of all sequences on a segment-by-segment basis. The diagnostic accuracy of MR imaging was assessed using receiver operating characterizing analysis. Lesion (hepatocellular carcinoma > 10 mm in diameter)-to-liver contrast-to-noise ratio was calculated on MR images.

RESULTS. Ferumoxides-enhanced MR imaging (Az = 0.971) was significantly more accurate (p < 0.05) than mangafodipir trisodium—enhanced MR imaging (Az = 0.950). The mean sensitivity of ferumoxides-enhanced MR imaging (86%) was significantly greater (p < 0.05) than that of mangafodipir trisodium—enhanced MR imaging (44%) in lesions smaller than 10 mm. The mean lesion-to-liver contrast-to-noise ratio of hepatocellular carcinoma on ferumoxides-enhanced MR imaging (13.7 ± 8.8) was significantly greater than on mangafodipir trisodium—enhanced MR imaging (5.4 ± 5.1) (p < 0.01).

CONCLUSION. Ferumoxides-enhanced MR imaging has superior diagnostic accuracy in lesions smaller than 10 mm and superior lesion conspicuity compared with mangafodipir trisodium—enhanced MR imaging for the preoperative detection of hepatocellular carcinoma.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
R. F. Hanna, N. Kased, S. W. Kwan, A. C. Gamst, A. C. Santosa, T. Hassanein, and C. B. Sirlin
Double-Contrast MRI for Accurate Staging of Hepatocellular Carcinoma in Patients with Cirrhosis
Am. J. Roentgenol., January 1, 2008; 190(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. J. Kim, K. W. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, M.-S. Lee, and M.-G. Lee
Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Am. J. Roentgenol., April 1, 2006; 186(4): 1059 - 1066.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. A. Bluemke, D. Sahani, M. Amendola, T. Balzer, J. Breuer, J. J. Brown, D. D. Casalino, P. L. Davis, I. R. Francis, G. Krinsky, et al.
Efficacy and Safety of MR Imaging with Liver-specific Contrast Agent: U.S. Multicenter Phase III Study
Radiology, October 1, 2005; 237(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
J A Guthrie
Cirrhosis and focal liver lesions: MRI findings
Imaging, September 1, 2004; 16(4): 351 - 363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.